Company can’t market cannabidiol products for Parkinson’s, Alzheimer’s, FDA and FTC say
By
Lois A. Bowers
Oct 23, 2019
A Florida company must stop marketing its unapproved cannabidiol products using unsubstantiated claims that the products treat Parkinson’s disease, Alzheimer’s disease and other conditions, the Food...
Model can predict cognitive decline in patients
By
Elizabeth Newman
Aug 05, 2019
People at risk for Alzheimer’s disease vary in how quickly cognitive decline may occur. But a new model predicts cognition test scores for up to two years and may lead to improving what medications are...
Meditation, music may prevent or slow cognitive decline: study
By
Lois A. Bowers
Jan 29, 2017
Meditating or listening to music may prevent or slow cognitive decline in older adults, according to new research.
More news for Thursday, Dec. 22
Dec 21, 2016
Sickness that killed three assisted living residents after Thanksgiving dinner identified … Fire officials stress importance of sprinklers in senior living … CBO issues report on long-term...
More news for Friday, Dec. 16
Dec 16, 2016
Tough choices ahead for new CMS boss … People with Alzheimer’s taking antipsychotics may face higher death risk … Many high-need patients missing out on help with ADLs, report shows
Wayfinding issues may be first sign of Alzheimer’s: research
By
Lois A. Bowers
Apr 25, 2016
People who have difficulty finding their way around may be showing the earliest signs of Alzheimer’s disease, according to new research. The study provides hope that one day a navigation skill test...
Circulation issue tied to psychosis in those with Alzheimer’s
By
Lois A. Bowers
Jan 06, 2016
A new study has found that cerebrovascular disease is a major determinant of psychosis in people who have Alzheimer’s disease.
Memory complaints may signal future impairment: study
By
Lois A. Bowers
Oct 28, 2015
Don’t ignore residents who complain of memory problems. New research explains the reason.
Tau identified as cause of Alzheimer’s
By
John O'Connor
Dec 01, 2014
Plaque has long been considered a prime suspect behind Alzheimer’s disease. But new findings are causing some investigators to cite tau instead.
AllyAlign gets $10 million in funding to accelerate its growth in senior living
By
Lois A. Bowers
Apr 17, 2019
Richmond, VA-based Medicare Advantage special need plans developer and administrator AllyAlign Health said it will use $10 million in investor funding to accelerate its growth with independent living,...